If We Can’t Prevent RA, Can We at Least Prevent Difficult-to-Treat RA? Despite major advances in RA management, some patients develop difficult-to-treat RA (D2TRA), characterized by ongoing inflammation and impairment despite multiple therapies. While understanding of the https://t.co/FcF0V82KdT